MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Intuitive Surgical Inc

Fermé

SecteurSoins de santé

446.1 2.79

Résumé

Variation du prix de l'action

24h

Actuel

Min

434.28

Max

449

Chiffres clés

By Trading Economics

Revenu

-40M

664M

Ventes

187M

2.4B

P/E

Moyenne du Secteur

60.602

36.442

Marge bénéficiaire

27.221

Employés

15,638

EBITDA

268M

987M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+34.95% upside

Dividendes

By Dow Jones

Prochains Résultats

21 oct. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-29B

156B

Ouverture précédente

443.31

Clôture précédente

446.1

Score Technique

By Trading Central

Confiance

Weak Bearish Evidence

Intuitive Surgical Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 juil. 2025, 21:13 UTC

Résultats

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22 avr. 2025, 20:55 UTC

Résultats

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23 janv. 2025, 21:41 UTC

Résultats

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21 janv. 2025, 18:37 UTC

Acquisitions, Fusions, Rachats

Intuitive to Establish Direct Presence in Europe With Acquisition

22 juil. 2025, 20:14 UTC

Résultats

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 juil. 2025, 20:13 UTC

Résultats

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 juil. 2025, 20:13 UTC

Résultats

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 juil. 2025, 20:05 UTC

Résultats

Intuitive Surgical 2Q Net $658.4M >ISRG

22 juil. 2025, 20:05 UTC

Résultats

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22 juil. 2025, 20:05 UTC

Résultats

Intuitive Surgical 2Q Rev $2.44B >ISRG

22 juil. 2025, 20:05 UTC

Résultats

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22 juil. 2025, 20:05 UTC

Résultats

Intuitive Surgical 2Q EPS $1.81 >ISRG

22 avr. 2025, 20:13 UTC

Résultats

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 avr. 2025, 20:05 UTC

Résultats

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 avr. 2025, 20:05 UTC

Résultats

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 avr. 2025, 20:05 UTC

Résultats

Intuitive Surgical 1Q Net $698.4M >ISRG

22 avr. 2025, 20:05 UTC

Résultats

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22 avr. 2025, 20:05 UTC

Résultats

Intuitive Surgical 1Q Rev $2.25B >ISRG

24 janv. 2025, 21:17 UTC

Résultats

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24 janv. 2025, 18:18 UTC

Résultats

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24 janv. 2025, 13:11 UTC

Actualités

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24 janv. 2025, 09:51 UTC

Actions en Tendance

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23 janv. 2025, 21:10 UTC

Résultats

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23 janv. 2025, 21:09 UTC

Résultats

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23 janv. 2025, 21:09 UTC

Résultats

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23 janv. 2025, 21:05 UTC

Résultats

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23 janv. 2025, 21:05 UTC

Résultats

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23 janv. 2025, 21:05 UTC

Résultats

Intuitive Surgical 4Q Rev $2.41B >ISRG

23 janv. 2025, 21:05 UTC

Résultats

Intuitive Surgical 4Q Net $685.7M >ISRG

23 janv. 2025, 21:05 UTC

Résultats

Intuitive Surgical 4Q EPS $1.88 >ISRG

Comparaison

Variation de prix

Intuitive Surgical Inc prévision

Objectif de Prix

By TipRanks

34.95% hausse

Prévisions sur 12 Mois

Moyen 586.53 USD  34.95%

Haut 685 USD

Bas 440 USD

Basé sur 20 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

20 ratings

15

Achat

4

Maintien

1

Vente

Score Technique

By Trading Central

514.59 / 539.05Support & Résistance

Court Terme

Weak Bearish Evidence

Moyen Terme

Weak Bullish Evidence

Long Terme

Strong Bullish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat